content: <html>
  <head>
       <title></title>
  </head>
  <BODY STYLE="font-size: 10pt">
  
  <p style="margin: 0">&#160;&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  April 19, 2017</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Ethema Health Corporation</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                           or other jurisdiction of</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                           Employer</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5734
                                           Yonge Street, Suite 300</B></FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Toronto,
          Ontario, Canada M2M 4E7</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
      of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(416)
      222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item</B></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.02 Termination of a Material Definitive Agreement.</B>&#9;</FONT></P>
  
  
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">On May 26, 2017 the Company
  repaid Labrys Fund LP $112,724.38 US, retiring a convertible note (the &quot;Note&quot;) payable to Labrys Fund LLP. The Note
  was issued on F<FONT STYLE="background-color: white">ebruary 2, 2017, in the principal amount of USD$110,000.00, bearing annual
  interest at 8% and maturing on August 2, 2017. In connection with the payoff of the Note, Labrys returned 1,200,000 shares of
  common stock of the Company which were being held by the lender in escrow. The escrowed shares were returned to treasury.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify">On April 19, 2017, Eileen
  Greene (&ldquo;Greene&rdquo;), wife of CEO Shawn Greene, advanced four hundred thousand and 00/100 Canadian dollars ($400,000.00
  CDN) to Ethema Health Corporation (the &ldquo;Company&rdquo;) as a short term loan. The loan is interest free and there are no
  fixed terms of repayment. The funds were used for working capital purposes and to repay corporate debt. The Company expects to
  repay this loan from proceeds of a mortgage refinancing that it intends to complete on its Canadian property in the very near
  future. On May 23, 2017 the Company sold a 25% share of a $700,000 CDN second mortgage that is registered against the Company's
  Canadian property to Yonge - McNairn Corporation Limited for net proceeds of $147,620.27. Yonge - McNairn Corporation Limited
  already owned 50% of the mortgage.</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 3.02&nbsp;Unregistered Sales of Equity
  Securities.</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify">On May 31, 2017 the Company
  settled a Consultant invoice of $5,000 US with the issuance of 100,000 restricted shares of Company common stock at the rate of
  $0.05 per share. The shares have been issued.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">In making the Consultant
  Issuance, Consultant made representations to the Company that he individually met the accredited investor definition of Rule 501
  of the Securities Act, and the Company relied on such representations. The Consultant Issuance were offered and sold without registration
  under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule
  506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">The Consultant Issuance
  was not conducted in connection with a public offering, and no public solicitation or advertisement was made or relied upon by
  the Consultant in connection with the offering. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation
  of an offer to buy, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption
  from the registration requirements.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="background-color: white"><B>[signature
  page follows]</B></FONT></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="background-color: white"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Date:
  June 2, 2017&#9;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">By: <U>/s/ Shawn E. Leon</U></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Name:
  Shawn E. Leon</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Title: CEO</FONT>&nbsp;</P>
  
  
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 3; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0"></p>
  
  </body>
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k060217.htm", "secsgml_size_bytes": 16586}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "17888693"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  April 19, 2017
  Ethema Health Corporation
  (Exact name of registrant as specified in its
  charter)
  Colorado
  000-15078
  84-1227328
  (State
                                           or other jurisdiction of
  incorporation
          or organization)
  (Commission
      File Number)
  (IRS
                                           Employer
  Identification
          No.)
  5734
                                           Yonge Street, Suite 300
  Toronto,
          Ontario, Canada M2M 4E7
  (Address
      of principal executive offices)
  (416)
      222-5501
  (Registrant's
      telephone number, including area code)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [
      ]
  Written
      communications pursuant to Rule 425 under the Securities Act
  [
      ]
  Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act
  [
      ]
  Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [
      ]
  Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Item
  1.02 Termination of a Material Definitive Agreement.
  On May 26, 2017 the Company
  repaid Labrys Fund LP $112,724.38 US, retiring a convertible note (the "Note") payable to Labrys Fund LLP. The Note
  was issued on F
  ebruary 2, 2017, in the principal amount of USD$110,000.00, bearing annual
  interest at 8% and maturing on August 2, 2017. In connection with the payoff of the Note, Labrys returned 1,200,000 shares of
  common stock of the Company which were being held by the lender in escrow. The escrowed shares were returned to treasury.
  Item
  2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
  On April 19, 2017, Eileen
  Greene ("Greene"), wife of CEO Shawn Greene, advanced four hundred thousand and 00/100 Canadian dollars ($400,000.00
  CDN) to Ethema Health Corporation (the "Company") as a short term loan. The loan is interest free and there are no
  fixed terms of repayment. The funds were used for working capital purposes and to repay corporate debt. The Company expects to
  repay this loan from proceeds of a mortgage refinancing that it intends to complete on its Canadian property in the very near
  future. On May 23, 2017 the Company sold a 25% share of a $700,000 CDN second mortgage that is registered against the Company's
  Canadian property to Yonge - McNairn Corporation Limited for net proceeds of $147,620.27. Yonge - McNairn Corporation Limited
  already owned 50% of the mortgage.
  Item 3.02 Unregistered Sales of Equity
  Securities.
  On May 31, 2017 the Company
  settled a Consultant invoice of $5,000 US with the issuance of 100,000 restricted shares of Company common stock at the rate of
  $0.05 per share. The shares have been issued.
  In making the Consultant
  Issuance, Consultant made representations to the Company that he individually met the accredited investor definition of Rule 501
  of the Securities Act, and the Company relied on such representations. The Consultant Issuance were offered and sold without registration
  under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule
  506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.
  The Consultant Issuance
  was not conducted in connection with a public offering, and no public solicitation or advertisement was made or relied upon by
  the Consultant in connection with the offering. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation
  of an offer to buy, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption
  from the registration requirements.
  [signature
  page follows]
  SIGNATURES
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  Date:
  June 2, 2017
  By:
  /s/ Shawn E. Leon
  Name:
  Shawn E. Leon
  Title: CEO